The Zhitong Finance App learned that on December 15, the US clinical trial listing website showed that LLY.US (LLY.US) initiated the first phase III clinical trial (ENLIGHTEN-2) of Eloralintide (LY3841136).

智通財經·12/16/2025 13:25:12

語音播報